INTRODUCTION
============

Meningioma accounts for approximately 20%-30% of all intracranial neoplasms and is the second most common neoplasm of the central nervous system \[[@b1-acfs-2018-19-1-55],[@b2-acfs-2018-19-1-55]\]. Meningiomas mainly occur in middle-aged women, and it is reported that women are almost twice as likely as men to develop intracranial meningiomas and five to 10 times more likely to develop spinal meningiomas. Most meningiomas are benign (World Health Organization \[WHO\] grade I), but 20% are atypical (WHO grade II), and 1% to 3% are so-called anaplastic (malignant) meningiomas \[[@b3-acfs-2018-19-1-55]\]. Rarely, meningiomas can be found in the extradural region. These extracranial meningiomas can be divided into primary extracranial meningioma and secondary extracranial meningioma depending on the presence of an intracranial tumor component \[[@b4-acfs-2018-19-1-55]\]. Among them, primary extracranial meningioma with no intracranial component is extremely rare (0.9%) \[[@b5-acfs-2018-19-1-55]\]. These primary extracranial meningiomas are likely to be misdiagnosed as other tumors due to the absence of characteristic symptoms. We present a case of histologically confirmed primary extracranial meningioma of the forehead skin.

CASE REPORT
===========

A 51-year-old male had a symptomless forehead mass of about 1-year duration. Excision was attempted at a private clinic but was discontinued due to excessive bleeding. At the time of presentation at National Health Insurance Service Ilsan Hospital (Ilsan, Korea), there was an approximately 1.5-cm-diameter firm protruding mass with an overlying 0.5-cm-long incision scar on the middle forehead ([Fig. 1](#f1-acfs-2018-19-1-55){ref-type="fig"}). An ultrasonogram showed a 2.05×1.36×0.49-cm benign-looking hyperechoic nodular lesion ([Fig. 2](#f2-acfs-2018-19-1-55){ref-type="fig"}). A subsequent computerized tomography (CT) scan showed that the lesion was confined to the extracranial location ([Fig. 3](#f3-acfs-2018-19-1-55){ref-type="fig"}). An excisional biopsy was performed under local anesthesia. During the excisional biopsy, the mass was difficult to grossly delineate from the overlying skin and was found to be adhered to the underlying frontalis muscle. Therefore, the mass was excised en-bloc in an elliptical shape including the skin and frontalis muscle. The wound was closed by primary repair. Histopathology showed a lobular architecture composed of tumor cells with eosinophilic cytoplasm and indistinct cell borders ([Fig. 4](#f4-acfs-2018-19-1-55){ref-type="fig"}). A few nuclear pseudoinclusions were also noted ([Fig. 5](#f5-acfs-2018-19-1-55){ref-type="fig"}). Diffuse granular cytoplasmic immunostaining was positive for epithelial membrane antigen ([Fig. 6](#f6-acfs-2018-19-1-55){ref-type="fig"}). These findings were consistent with an extracranial meningioma. A brain computed tomography scan showed no remarkable findings in the intracranial structures. Therefore, a final diagnosis of primary extracranial meningioma was made. Currently, there is no evidence of recurrence at 3 years after surgery.

DISCUSSION
==========

Extracranial meningiomas are classified according to Hoye et al. \[[@b4-acfs-2018-19-1-55]\]. Primary extracranial meningioma and secondary extracranial meningioma can be classified according to the presence or absence of an intracranial meningioma. Primary extracranial meningiomas are composed of two types: a tumor originating from arachnoid cells remaining in the nerve sheaths and a tumor occurring ectopically without connection to the cranium. Secondary extracranial meningiomas are classified as intracranial tumors directly escaping from the cranium and extracranial meningioma that has metastasized from an intracranial meningioma \[[@b6-acfs-2018-19-1-55]\]. According to this classification, our case is classified as an ectopic primary extracranial meningioma.

Intradural meningioma is known to be associated with radiation, virus, head trauma, smoking, nitrate, and high cholesterol levels, but the cause of primary extracranial meningioma is not yet clear. Possible hypotheses are as follows: (1) migration of arachnoid cells along the cranial nerve sheath; (2) proliferation of extradural arachnoid cells that have become disarranged during embryogenesis; (3) displacement of arachnoid islets by trauma or cerebral hypertension; (4) origination from pluripotent mesenchymal cells.

Rushing et al. \[[@b1-acfs-2018-19-1-55]\] examined 146 cases of primary extracranial meningiomas. The ratio of males to females was 74 to 72, showing similar incidence between sexes. The most common location was skin and scalp (40.4%), followed by middle ear (17.8%), and nasal cavity (11.6%). Tumor size ranged from 0.5 cm to 4.5 cm, with an average of 1.2 cm. Extracranial meningioma usually shows a simple polyp-like appearance of a firm to rubbery mass, and it is not easy to distinguish from other masses \[[@b7-acfs-2018-19-1-55]\]. Therefore, different types of benign or malignant tumors should be differentiated according to anatomical location.

It is also difficult to diagnose extracranial meningioma on CT scan. It usually appears as a homogeneous enhancing mass, and calcification can occur. A magnetic resonance imaging scan shows a homogeneous mass with similar signal intensity to the brain parenchyma \[[@b8-acfs-2018-19-1-55]\]. Vascular flow is often not visible on angiography \[[@b9-acfs-2018-19-1-55]\].

Therefore, the final diagnosis is confirmed by pathology. Meningiomas have various pathologic findings, including meningiothelial (syncytial), fibrous, psammomatous, angiomatous, and transitional meningioma \[[@b3-acfs-2018-19-1-55]\]. Our patient showed a meningiothelial pattern. The mass was composed of uniform tumor cells forming lobules, surrounded by collagenous septae. Ill-defined cell borders were seen within the lobules. It also showed a characteristic nuclear change, including a clear space called the pseudoinclusion. Immunohistochemistry is essential for the diagnosis of extracranial meningioma. Meningiomas are positive for epithelial membrane antigen and vimentin and can be positive for S-100 protein, cytokeratin, and desmin \[[@b10-acfs-2018-19-1-55]\]. These results were all seen in our patient.

Extracranial meningioma is a rare tumor of the head and neck. If extracranial meningioma is diagnosed pathologically, it is important to confirm the presence of an intracranial component by radiological examination. Treatment of choice for extracranial meningioma is complete surgical resection. Recurrence after complete resection is rare. \[[@b10-acfs-2018-19-1-55],[@b11-acfs-2018-19-1-55]\].
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![Ultrasonographic findings showed a 2.05×1.36×0.49-cm benign-looking hyperechoic nodular lesion on forehead. There were no abnormal vascular flow.](acfs-2018-19-1-55f2){#f2-acfs-2018-19-1-55}

![Brain computerized tomography scan with various windows showed a tiny hyperdense lesion adjacent to the frontal bone. There was no other remarkable finding in the intracranial structures.](acfs-2018-19-1-55f3){#f3-acfs-2018-19-1-55}

![Lobular architecture composed of tumor cells with eosinophilic cytoplasm and indistinct cell border (H&E, ×200).](acfs-2018-19-1-55f4){#f4-acfs-2018-19-1-55}

![A few nuclear pseudoinclusions (arrow) (H&E, ×400).](acfs-2018-19-1-55f5){#f5-acfs-2018-19-1-55}

![Diffuse granular cytoplasmic immunostaining for epithelial membrane antigen (×400).](acfs-2018-19-1-55f6){#f6-acfs-2018-19-1-55}
